Inventor · disambiguated record
Michael David Woodrow
Also filed as: WOODROW MICHAEL · WOODROW MICHAEL D · WOODROW MICHAEL DAVID
14 granted patents·6 pending applications·49 citations·filing 2004–2022
88Inventor score
Files withMISSION THERAPEUTICS LTD11GLAXO GROUP LTD3ANCLIFF RACHAEL ANN2BALDWIN IAN ROBERT1DEMONT EMMANUEL HUBERT1
Top patents by PatentIndex Score
20 records- 0189US8697725B2Tetrahydroquinoline derivatives and their pharmaceutical useDEMONT EMMANUEL HUBERT·Filed 2010·Granted Apr 15, 2014·19 cites·17 claims
- 0285US10640498B2CompoundsMISSION THERAPEUTICS LTD·Filed 2017·Granted May 5, 2020·6 cites·17 claims
- 0385US7572915B2Quinoline derivatives as phosphodiesterase inhibitorsGLAXO GROUP LTD·Filed 2006·Granted Aug 11, 2009·9 cites·11 claims
- 0479US7566786B2Quinoline derivatives as phosphodiesterase inhibitorsGLAXO GROUP LTD·Filed 2004·Granted Jul 28, 2009·14 cites·23 claims
- 0572US10683269B22-cyanoisoindoline derivatives for treating cancerMISSION THERAPEUTICS LTD·Filed 2017·Granted Jun 16, 2020·1 cites·15 claims
- 0670US2022106315A1Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes (dub) inhibitorsMISSION THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0768US11945797B21-cyano-pyrrolidine derivatives as dub inhibitorsMISSION THERAPEUTICS LTD·Filed 2022·Granted Apr 2, 2024·0 cites·15 claims
- 0866US11236092B2Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes (DUB) inhibitorsMISSION THERAPEUTICS LTD·Filed 2020·Granted Feb 1, 2022·0 cites·10 claims
- 0960US2009312325A1Quinoline Derivatives As Phosphodiesterase InhibitorsBALDWIN IAN ROBERT·Filed 2009·Application pending·0 cites
- 1053US10654853B2Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes (DUB) inhibitorsMISSION THERAPEUTICS LTD·Filed 2017·Granted May 19, 2020·0 cites·10 claims
- 1148US11352339B21-cyano-pyrrolidine derivatives as DUB inhibitorsMISSION THERAPEUTICS LTD·Filed 2017·Granted Jun 7, 2022·0 cites·15 claims
- 1248US8357716B2Pyrazole derivatives used as CCR4 receptor antagonistsGLAXO GROUP LTD·Filed 2010·Granted Jan 22, 2013·0 cites·16 claims
- 1346US11414402B2Sulfonamide-substituted cyanopyrrolidines with activity as DUB inhibitorsMISSION THERAPEUTICS LTD·Filed 2018·Granted Aug 16, 2022·0 cites·14 claims
- 1445US2007191426A1Derivatives of 3-aminocarbonylquinoline, pharmaceutical compositions containing them and processes and intermediates for their preparationEDLIN CHRISTOPHER·Filed 2004·Application pending·0 cites
- 1543US2008096884A14-Aminoquinoline-3-Carboxamide Derivatives as Pde4 InhibitorsEDLIN CHRISTOPHER D·Filed 2004·Application pending·0 cites
- 1641US11014912B2Cyanopyrrolidine derivatives with activity as inhibitors of USP30MISSION THERAPEUTICS LTD·Filed 2017·Granted May 25, 2021·0 cites·17 claims
- 1740US11306096B24,6 dihydropyrrolo [3,4-C] pyrazole-5 (1H)-carbonitrile derivates for treating cancerMISSION THERAPEUTICS LTD·Filed 2017·Granted Apr 19, 2022·0 cites·11 claims
- 1840US10590075B2Cyanopyrrolidine derivatives as inhibitors for DUBsMISSION THERAPEUTICS LTD·Filed 2016·Granted Mar 17, 2020·0 cites·18 claims
- 1940US2008207638A1CompoundsANCLIFF RACHAEL ANN·Filed 2006·Application pending·0 cites
- 2039US2008275027A1Piperazinone Derivatives Useful as Histamine H3 Receptor Antagonists and/or Inverse AgonistsANCLIFF RACHAEL ANN·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →